1. Home
  2. PLX vs EWCZ Comparison

PLX vs EWCZ Comparison

Compare PLX & EWCZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLX
  • EWCZ
  • Stock Information
  • Founded
  • PLX 1993
  • EWCZ 2004
  • Country
  • PLX United States
  • EWCZ United States
  • Employees
  • PLX N/A
  • EWCZ N/A
  • Industry
  • PLX Biotechnology: Biological Products (No Diagnostic Substances)
  • EWCZ Package Goods/Cosmetics
  • Sector
  • PLX Health Care
  • EWCZ Consumer Discretionary
  • Exchange
  • PLX Nasdaq
  • EWCZ Nasdaq
  • Market Cap
  • PLX 160.2M
  • EWCZ 137.7M
  • IPO Year
  • PLX 1998
  • EWCZ 2021
  • Fundamental
  • Price
  • PLX $1.55
  • EWCZ $5.12
  • Analyst Decision
  • PLX Strong Buy
  • EWCZ Buy
  • Analyst Count
  • PLX 1
  • EWCZ 7
  • Target Price
  • PLX $15.00
  • EWCZ $5.86
  • AVG Volume (30 Days)
  • PLX 1.4M
  • EWCZ 932.4K
  • Earning Date
  • PLX 05-09-2025
  • EWCZ 05-14-2025
  • Dividend Yield
  • PLX N/A
  • EWCZ N/A
  • EPS Growth
  • PLX N/A
  • EWCZ N/A
  • EPS
  • PLX 0.05
  • EWCZ 0.21
  • Revenue
  • PLX $59,764,000.00
  • EWCZ $216,469,000.00
  • Revenue This Year
  • PLX $65.02
  • EWCZ N/A
  • Revenue Next Year
  • PLX $57.34
  • EWCZ $2.39
  • P/E Ratio
  • PLX $32.18
  • EWCZ $24.77
  • Revenue Growth
  • PLX 0.18
  • EWCZ N/A
  • 52 Week Low
  • PLX $0.82
  • EWCZ $2.72
  • 52 Week High
  • PLX $3.10
  • EWCZ $12.04
  • Technical
  • Relative Strength Index (RSI)
  • PLX 30.03
  • EWCZ 63.91
  • Support Level
  • PLX $1.54
  • EWCZ $5.08
  • Resistance Level
  • PLX $1.79
  • EWCZ $5.60
  • Average True Range (ATR)
  • PLX 0.11
  • EWCZ 0.34
  • MACD
  • PLX -0.02
  • EWCZ 0.04
  • Stochastic Oscillator
  • PLX 27.27
  • EWCZ 73.23

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.

About EWCZ European Wax Center Inc.

European Wax Center Inc is a franchisor and operator of OOH waxing services. Its product sales consist of revenue earned from sales of proprietary wax. Its services include Brazilian Waxing, Brow Waxing, Body Waxing, Facial Waxing, All Waxing Services, Eyebrow Tinting, Laser Hair Removal, Men's Waxing Services and others.

Share on Social Networks: